Last Updated: February, 2026
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing a Durlobactam production plant. It encompasses all critical aspects necessary for Durlobactam production, including the cost of Durlobactam production, Durlobactam plant cost, Durlobactam production costs, and the overall Durlobactam production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Durlobactam production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Durlobactam is a synthetic antibacterial agent that is mainly used in the pharmaceutical and healthcare sectors. It is primarily used as a beta-lactamase inhibitor in combination with certain antibiotics to treat serious bacterial infections caused by drug-resistant pathogens. It helps restore the effectiveness of antibiotics by blocking enzymes that bacteria use to break down these drugs.
It is especially useful in treating complicated infections caused by multidrug-resistant Gram-negative bacteria. It is mainly used in hospitals for treating critically ill patients, especially those on ventilators or with infections caused by Acinetobacter species. In clinical practice, it supports the management of hospital-acquired and severe infections where treatment options are limited. Moreover, Durlobactam is also used in antimicrobial research to study resistance mechanisms and to develop improved combination therapies for difficult-to-treat infections.
The market for Durlobactam is predominantly driven by its application as an antibacterial agent in the treatment of serious bacterial infections, which promotes its demand in the medical and healthcare sectors. Its application as a drug in combination with sulbactam for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia also boosts its demand in the pharmaceutical industry. Its demand as an effective antibiotic drug for combating multidrug-resistant pathogens also makes it a highly sought-after commodity among the healthcare and pharmaceutical industries.
Industrial Durlobactam procurement depends on factors such as the availability and cost of specialised raw materials, regulatory approvals for combination therapies, and adherence to stringent production and quality control standards. Developments in antibiotic innovation, supplier consistency, cold chain distribution, and alignment with global antimicrobial stewardship programs also impact its procurement strategies worldwide.
According to the Durlobactam production plant project report, the major raw materials for Durlobactam production include Glyoxylic Acid Monohydrate and (S)-tert-butylsulfinamide, Crotylboronic Acid, and Hydroxyurea 6-hydroxy-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxylic acid amide.
The extensive Durlobactam production cost report consists of the following industrial production process:
Durlobactam is a diazabicyclooctane non-beta-lactam beta-lactamase inhibitor, and it functions as a broad-spectrum inhibitor of Ambler Class A, C, and D serine beta-lactamases. It appears as a white to yellow amorphous powder or lyophilised solid cake that is freely soluble in water and readily dissolves in sterile water for injection upon reconstitution. The molecular formula of the compound is C8H11N3O6S, and its molecular mass is 277.25 g/mol. It exists as the pure (2S,5R)-enantiomer of the trans diastereoisomer. It is formulated as a sterile lyophilised powder for injection available in amber single-dose vials containing 0.5 g per vial, which must be reconstituted with 2.5 mL of sterile water for injection. It has a density of 1.81 g/cm3. The compound must be stored refrigerated at 2 degree Celsius to 8 degree Celsius in the original carton and should not be frozen. Extended exposure to this antibacterial agent requires close monitoring for infusion reactions, liver function abnormalities, and proper dosage adjustment in patients with renal impairment or augmented renal clearance.
Durlobactam Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Durlobactam |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Durlobactam but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Durlobactam market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Vishakha Agrawal
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
